Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-296490

Monte Rosa Therapeutics, Inc. · GLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 5:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001826457

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jul 1, 2026J1,000,000$0.00D6,692,298ISee Note 2
Common StockF4Jul 1, 2026J15,000$0.00A15,000ISee Note 4
Common StockF4Jul 1, 2026J15,000$0.00D0ISee Note 4

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses